FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100010083> ?p ?o ?g. }

• W3100010083 abstract "Introduction Glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency is the most common enzymopathy in humans, and its distribution has been historically described to be closely associated with that of malaria. North East India provides optimal conditions for transmission of malaria and bears a considerable burden of Plasmodium vivax (P. vivax) malaria. Primaquine, a mainstay in the treatment of vivax malaria, may trigger episodes of acute hemolysis in patients with G6PD deficiency. The present study sought to delineate the frequency and genotypes of G6PD deficiency among patients suffering from vivax malaria infections. Methods Blood specimens from 80 individuals diagnosed with vivax malaria underwent enzyme assay for G6PD deficiency. Samples with deficient phenotype underwent isolation of DNA using a genomic DNA isolation kit (Qiagen India Pvt. Ltd., New Delhi, India). The genomic DNA underwent amplification, serial denaturation, annealing, extension, final extension followed by digestion with restriction endonucleases Nla III and Fok I. The digested products were subjected to horizontal agarose electrophoresis for the separation of digested fragments. Samples without nucleotide 376 adenine→guanine (A→G) mutation were classified as G6PD B. Those with the mutation were further classified into G6PD A(+) and G6PD A(-) based on the presence of Nla III site. Results Twenty-seven out of 80 individuals (33.75%) with P. vivax malaria were found to have G6PD deficiency, of which a majority (n=24) had G6PD B genotype. Three individuals had Asparagine→Aspartic Acid mutation at position 376 (A→G), of which G6PD A(+) and G6PD A(-) were present in two and one cases, respectively. Conclusion G6PD deficiency was noted in about a third of patients with vivax malaria. Since primaquine therapy is contraindicated in this group of patients, there is a rationale for looking into screening patients with vivax malaria from the region prior to primaquine therapy. Further large scale studies may substantiate this and help in better genotypic and geographic characterization of G6PD deficiency in the region." @default.
• W3100010083 created "2020-11-23" @default.
• W3100010083 creator A5008841335 @default.
• W3100010083 creator A5009972737 @default.
• W3100010083 creator A5029840168 @default.
• W3100010083 creator A5030416091 @default.
• W3100010083 creator A5042835577 @default.
• W3100010083 creator A5048902549 @default.
• W3100010083 creator A5071416796 @default.
• W3100010083 creator A5073856778 @default.
• W3100010083 creator A5076353772 @default.
• W3100010083 creator A5089348029 @default.
• W3100010083 date "2020-11-12" @default.
• W3100010083 modified "2023-09-23" @default.
• W3100010083 title "Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India" @default.
• W3100010083 cites W10637832 @default.
• W3100010083 cites W1883239929 @default.
• W3100010083 cites W1964890051 @default.
• W3100010083 cites W1982046776 @default.
• W3100010083 cites W2009770922 @default.
• W3100010083 cites W2038410803 @default.
• W3100010083 cites W2073881166 @default.
• W3100010083 cites W2088718155 @default.
• W3100010083 cites W2090860030 @default.
• W3100010083 cites W2092624381 @default.
• W3100010083 cites W2099098778 @default.
• W3100010083 cites W2099227149 @default.
• W3100010083 cites W2146306390 @default.
• W3100010083 cites W2148278340 @default.
• W3100010083 cites W2340290507 @default.
• W3100010083 cites W2530314644 @default.
• W3100010083 cites W2611432246 @default.
• W3100010083 cites W266468940 @default.
• W3100010083 cites W2802360567 @default.
• W3100010083 cites W2900271397 @default.
• W3100010083 cites W2950607694 @default.
• W3100010083 cites W2979613194 @default.
• W3100010083 cites W2995124727 @default.
• W3100010083 cites W2995429862 @default.
• W3100010083 cites W3082316445 @default.
• W3100010083 cites W327699451 @default.
• W3100010083 doi "https://doi.org/10.7759/cureus.11463" @default.
• W3100010083 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7671175" @default.
• W3100010083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33214970" @default.
• W3100010083 hasPublicationYear "2020" @default.
• W3100010083 type Work @default.
• W3100010083 sameAs 3100010083 @default.
• W3100010083 citedByCount "1" @default.
• W3100010083 countsByYear W31000100832022 @default.
• W3100010083 crossrefType "journal-article" @default.
• W3100010083 hasAuthorship W3100010083A5008841335 @default.
• W3100010083 hasAuthorship W3100010083A5009972737 @default.
• W3100010083 hasAuthorship W3100010083A5029840168 @default.
• W3100010083 hasAuthorship W3100010083A5030416091 @default.
• W3100010083 hasAuthorship W3100010083A5042835577 @default.
• W3100010083 hasAuthorship W3100010083A5048902549 @default.
• W3100010083 hasAuthorship W3100010083A5071416796 @default.
• W3100010083 hasAuthorship W3100010083A5073856778 @default.
• W3100010083 hasAuthorship W3100010083A5076353772 @default.
• W3100010083 hasAuthorship W3100010083A5089348029 @default.
• W3100010083 hasBestOaLocation W31000100831 @default.
• W3100010083 hasConcept C104317684 @default.
• W3100010083 hasConcept C126322002 @default.
• W3100010083 hasConcept C135763542 @default.
• W3100010083 hasConcept C159047783 @default.
• W3100010083 hasConcept C203014093 @default.
• W3100010083 hasConcept C2776793103 @default.
• W3100010083 hasConcept C2777425658 @default.
• W3100010083 hasConcept C2778048844 @default.
• W3100010083 hasConcept C2778119762 @default.
• W3100010083 hasConcept C2778371730 @default.
• W3100010083 hasConcept C2779997623 @default.
• W3100010083 hasConcept C54355233 @default.
• W3100010083 hasConcept C71924100 @default.
• W3100010083 hasConcept C86803240 @default.
• W3100010083 hasConceptScore W3100010083C104317684 @default.
• W3100010083 hasConceptScore W3100010083C126322002 @default.
• W3100010083 hasConceptScore W3100010083C135763542 @default.
• W3100010083 hasConceptScore W3100010083C159047783 @default.
• W3100010083 hasConceptScore W3100010083C203014093 @default.
• W3100010083 hasConceptScore W3100010083C2776793103 @default.
• W3100010083 hasConceptScore W3100010083C2777425658 @default.
• W3100010083 hasConceptScore W3100010083C2778048844 @default.
• W3100010083 hasConceptScore W3100010083C2778119762 @default.
• W3100010083 hasConceptScore W3100010083C2778371730 @default.
• W3100010083 hasConceptScore W3100010083C2779997623 @default.
• W3100010083 hasConceptScore W3100010083C54355233 @default.
• W3100010083 hasConceptScore W3100010083C71924100 @default.
• W3100010083 hasConceptScore W3100010083C86803240 @default.
• W3100010083 hasLocation W31000100831 @default.
• W3100010083 hasLocation W31000100832 @default.
• W3100010083 hasLocation W31000100833 @default.
• W3100010083 hasOpenAccess W3100010083 @default.
• W3100010083 hasPrimaryLocation W31000100831 @default.
• W3100010083 hasRelatedWork W1960200814 @default.
• W3100010083 hasRelatedWork W2063737269 @default.
• W3100010083 hasRelatedWork W2131162525 @default.
• W3100010083 hasRelatedWork W2155715046 @default.
• W3100010083 hasRelatedWork W2792037775 @default.
• W3100010083 hasRelatedWork W2803848661 @default.

• next